On Wednesday, NFL commissioner Roger Goodell announced that the league welcomes an investigation into how the Philadelphia Eagles handled the medical care of quarterback Jalen Hurts following the discovery of blood clots in the player’s system.

Goodell’s statement, reported by ESPN, signals the NFL’s intent to examine the Eagles’ protocols and the medical team’s response to a serious health concern that emerged during the season. While the details of the investigation have not yet been disclosed, it is expected to review the timing, communication, and treatment decisions made by the Eagles’ medical staff.

The move underscores the league’s ongoing commitment to player safety and transparency. Blood clots can pose life‑threatening risks, and how teams manage such conditions has become a focal point for scrutiny in professional football. By welcoming scrutiny, the NFL demonstrates that it is prepared to hold teams accountable for the health and well‑being of their athletes.

As the investigation unfolds, the league may issue recommendations or mandate procedural changes to prevent similar incidents in the future. The outcome could influence medical protocols across the NFL, potentially leading to stricter guidelines for diagnosing and treating blood clotting disorders in players.